Attached files
| file | filename |
|---|---|
| EX-10.25 - EX-10.25 - Cullinan Oncology, Inc. | d19045dex1025.htm |
| EX-10.22 - EX-10.22 - Cullinan Oncology, Inc. | d19045dex1022.htm |
| EX-10.2 - EX-10.2 - Cullinan Oncology, Inc. | d19045dex102.htm |
| EX-10.1 - EX-10.1 - Cullinan Oncology, Inc. | d19045dex101.htm |
| EX-5.1 - EX-5.1 - Cullinan Oncology, Inc. | d19045dex51.htm |
| EX-4.3 - EX-4.3 - Cullinan Oncology, Inc. | d19045dex43.htm |
| EX-3.7 - EX-3.7 - Cullinan Oncology, Inc. | d19045dex37.htm |
| EX-3.6 - EX-3.6 - Cullinan Oncology, Inc. | d19045dex36.htm |
| EX-3.5 - EX-3.5 - Cullinan Oncology, Inc. | d19045dex35.htm |
| EX-3.4 - EX-3.4 - Cullinan Oncology, Inc. | d19045dex34.htm |
| EX-3.2 - EX-3.2 - Cullinan Oncology, Inc. | d19045dex32.htm |
| EX-2.1 - EX-2.1 - Cullinan Oncology, Inc. | d19045dex21.htm |
| EX-1.1 - EX-1.1 - Cullinan Oncology, Inc. | d19045dex11.htm |
| S-1/A - S-1/A - Cullinan Oncology, Inc. | d19045ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Cullinan Oncology, LLC:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
January 4, 2021